Trademarks = 4

Forward Citations = 3

Loading Chart...

8 inventors (with patents filed for the assignee):

John Lewis (5 out of 7 patents)

Roy Duncan (4 out of 6 patents)

Eileen Kathryn Clancy (3 out of 3 patents)

4. Roberto Justo De Antueno (3 out of 3 patents)

5. Rae-Lynn Nesbitt (3 out of 3 patents)

6. Konstantin Stoletov (2 out of 2 patents)

7. Lian Willetts (2 out of 2 patents)

8. Chungen Pan (1 out of 7 patents)

6 patents: Sort by Forward Citations

1. 12454557 - Recombinant polypeptides for membrane fusion and uses thereof (2025-10-28),

2. 12421514 - Methods for diagnosing and treating metastatic cancer (2025-09-23),

3. 12378289 - Recombinant oncolytic viruses for treatment of metastatic cancers (2025-08-05),

4. 11459362 - Recombinant polypepties for membrane fusion and uses thereof (2022-10-04),

5. 11236331 - Methods for diagnosing and treating metastatic cancer (2022-02-01),

6. 10227386 - Recombinant polypeptides for membrane fusion and uses thereof (2019-03-12),

Company Overview

Entos Pharmaceuticals Inc. is a biotechnology company focused on developing innovative therapies for various diseases. The company specializes in the use of its proprietary drug delivery platform, which enhances the efficacy and safety of therapeutic agents. With a commitment to advancing healthcare, Entos aims to address unmet medical needs through its research and development efforts. The team comprises experienced professionals dedicated to bringing transformative solutions to patients. Entos is actively engaged in collaborations and partnerships to accelerate the development of its product pipeline.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#47 in Edmonton

#2,420 in Canada

Edmonton, Canada

Entos Pharmaceuticals Inc.

Forward Citations = 3

8 inventors:

John Lewis (5 out of 7 patents)

Roy Duncan (4 out of 6 patents)

Eileen Kathryn Clancy (3 out of 3 patents)

4. Roberto Justo De Antueno (3 out of 3 patents)

5. Rae-Lynn Nesbitt (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Entos Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/entos-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]